Phase Ib/II neoadjuvant (N-) pembrolizumab (P) and chemotherapy for locally advanced urothelial cancer (laUC): Final results from the cisplatin (C)- eligible cohort of HCRN GU14-188.

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Hoimes, CJ; Adra, N; Fleming, MT; Kaimakliotis, HZ; Picus, J; Smith, ZL; Walling, R; Trabulsi, EJ; Hoffman-Censits, JH; Koch, MO; Cary, C; Abouassaly, R; Eitman, C; Fu, P; Goolamier, G; Calaway, AC; Ponsky, LE; Kelly, WK

Published Date

  • May 20, 2020

Published In

Volume / Issue

  • 38 / 15

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X